C

Capital Digestive Care | Chevy Chase Clinical Research

Research site
(Unclaimed)
Location
5550 Friendship Boulevard, Suite T-90, Chevy Chase, Maryland, United States of America

Site insights

Top conditions

Top treatments

Golimumab
Fospropofol Disodium
Guselkumab
Adalimumab
Etrasimod
RPC1063
Ontamalimab
PEG-Interferon
AMT-101
Interferon

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 51 total trials

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337
Locations recently updated

The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.

Enrolling
Crohn's Disease
Biological: JNJ-78934804
Biological: Golimumab
Locations recently updated

The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderat...

Enrolling
Colitis, Ulcerative
Biological: JNJ-78934804
Drug: Placebo
Locations recently updated

A study to investigate bowel urgency in adults with moderately to severely active ulcerative colitis (UC) treated with mirikizumab. The study will ha...

Enrolling
Ulcerative Colitis Chronic
Ulcerative Colitis
Drug: Mirikizumab

The purpose of this study is to explore the safety, efficacy, effects on quality of life (QOL), and biomarker response of ozanimod in participants wi...

Enrolling
Colitis, Ulcerative
Drug: Ozanimod

Randomized, Placebo-controlled, Double-blind, Parallel-group, Multicenter, Phase 2a Study of the Efficacy and Safety of Oral AMT-101 in Subjects with...

Active, not recruiting
Ulcerative Colitis
Other: Placebo (oral)
Drug: AMT-101 (oral)

Trial sponsors

Celgene logo
Exact Sciences Corporation logo
Shire logo
Bausch Health logo
Eisai logo
J
Abbott logo
A
A
Bristol-Myers Squibb (BMS) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems